Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022. Further information about the Annual Update in Intensive Care and Emergency Med...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauer, Andrea, Putensen, Christian, Bode, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951664/
https://www.ncbi.nlm.nih.gov/pubmed/35337355
http://dx.doi.org/10.1186/s13054-022-03909-1
_version_ 1784675443180306432
author Sauer, Andrea
Putensen, Christian
Bode, Christian
author_facet Sauer, Andrea
Putensen, Christian
Bode, Christian
author_sort Sauer, Andrea
collection PubMed
description This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901.
format Online
Article
Text
id pubmed-8951664
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89516642022-03-27 Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option? Sauer, Andrea Putensen, Christian Bode, Christian Crit Care Review This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901. BioMed Central 2022-03-22 /pmc/articles/PMC8951664/ /pubmed/35337355 http://dx.doi.org/10.1186/s13054-022-03909-1 Text en © Sauer et al. 2022
spellingShingle Review
Sauer, Andrea
Putensen, Christian
Bode, Christian
Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
title Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
title_full Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
title_fullStr Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
title_full_unstemmed Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
title_short Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
title_sort immunomodulation by tetracyclines in the critically ill: an emerging treatment option?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951664/
https://www.ncbi.nlm.nih.gov/pubmed/35337355
http://dx.doi.org/10.1186/s13054-022-03909-1
work_keys_str_mv AT sauerandrea immunomodulationbytetracyclinesinthecriticallyillanemergingtreatmentoption
AT putensenchristian immunomodulationbytetracyclinesinthecriticallyillanemergingtreatmentoption
AT bodechristian immunomodulationbytetracyclinesinthecriticallyillanemergingtreatmentoption

Ejemplares similares